Literature DB >> 16602107

Survival of Parkinson's disease patients in a large prospective cohort of male health professionals.

Honglei Chen1, Shumin M Zhang, Michael A Schwarzschild, Miguel A Hernán, Alberto Ascherio.   

Abstract

Parkinson's disease (PD) patients have higher mortality than individuals without PD. However, most of the previous studies were based on prevalent cases and few examined the potential effects of duration and smoking on the survival of PD patients. We compared the survival experience of 288 men with incident PD diagnosed between 1986 and 2000 with that of 51,012 men free of PD in the Health Professionals Follow-up Study. As of January 2002, 92 deaths occurred among PD cases and 8,485 among men without PD. After controlling for age, men with PD had 60% higher mortality than those without PD (95% CI: 1.3-2.0). PD mortality was strongly related to disease duration: compared with men without PD, the age-adjusted relative risk for PD patients was 1.1 during the first 5 years from diagnosis, 2.3 from 5 to 10 years, and 3.5 after 10 years (P < 0.0001 for trend). As expected, cigarette smoking was strongly and positively associated with total mortality among men free of PD (comparing >30 pack-years vs. never smokers, relative risk, 2.0; P < 0.0001 for trend), but this association was not observed among PD patients (RR: 1.0; P = 0.95 for trend). This study confirms that PD patients have a higher mortality than individuals without PD and that the excess mortality increases with disease duration. However, smoking seems to impose little additional risk among PD patients in this large cohort of health professionals. (c) 2006 Movement Disorder Society.

Entities:  

Mesh:

Year:  2006        PMID: 16602107     DOI: 10.1002/mds.20881

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  25 in total

1.  Estimation of Parkinson's disease survival in Israeli men and women, using health maintenance organization pharmacy data in a unique approach.

Authors:  O Chillag-Talmor; N Giladi; S Linn; T Gurevich; B El-Ad; B Silverman; N Friedman; C Peretz
Journal:  J Neurol       Date:  2012-07-07       Impact factor: 4.849

2.  Estimated life expectancy of Parkinson's patients compared with the UK population.

Authors:  Lianna S Ishihara; Anne Cheesbrough; Carol Brayne; Anette Schrag
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-03-30       Impact factor: 10.154

3.  In search of the causes of Parkinson's disease, seasons 1 to 4.

Authors:  Alexis Elbaz
Journal:  Eur J Epidemiol       Date:  2011-05-31       Impact factor: 8.082

4.  Factors affecting survival of patients with neurodegenerative disease.

Authors:  Kyle Steenland; Jessica MacNeil; Ryan Seals; Allan Levey
Journal:  Neuroepidemiology       Date:  2010-04-08       Impact factor: 3.282

5.  Predictors of survival in patients with Parkinson disease.

Authors:  Allison W Willis; Mario Schootman; Nathan Kung; Bradley A Evanoff; Joel S Perlmutter; Brad A Racette
Journal:  Arch Neurol       Date:  2012-05

6.  Mortality and Its Risk Factors in Patients with Rapid Eye Movement Sleep Behavior Disorder.

Authors:  Junying Zhou; Jihui Zhang; Siu Ping Lam; Vincent Mok; Anne Chan; Shirley Xin Li; Yaping Liu; Xiangdong Tang; Wing Ho Yung; Yun Kwok Wing
Journal:  Sleep       Date:  2016-08-01       Impact factor: 5.849

7.  Smoking cessation for the neurologic patient.

Authors:  Jinny Tavee
Journal:  Neurol Clin Pract       Date:  2012-06

8.  Smoking duration, intensity, and risk of Parkinson disease.

Authors:  H Chen; X Huang; X Guo; R B Mailman; Y Park; F Kamel; D M Umbach; Q Xu; A Hollenbeck; A Schatzkin; A Blair
Journal:  Neurology       Date:  2010-03-10       Impact factor: 9.910

9.  Temporal relationship between cigarette smoking and risk of Parkinson disease.

Authors:  E L Thacker; E J O'Reilly; M G Weisskopf; H Chen; M A Schwarzschild; M L McCullough; E E Calle; M J Thun; A Ascherio
Journal:  Neurology       Date:  2007-03-06       Impact factor: 9.910

10.  Motor and non-motor function predictors of mortality in Parkinson's disease.

Authors:  Paulo Bugalho; Filipa Ladeira; Raquel Barbosa; João Pedro Marto; Claudia Borbinha; Manuel Salavisa; Laurete da Conceição; Marlene Saraiva; Marco Fernandes; Bruna Meira
Journal:  J Neural Transm (Vienna)       Date:  2019-08-05       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.